Simplex Trading’s ProShares UltraShort Health Care RXD Stock Holding History

Simplex Trading’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-81	Closed	-$1.98K	–	9594
2025 Q1	$1K	Buy	81 +50	+161%	+$1.08K	﹤0.01%	8297
2024 Q4	$0	Buy	+31	New	+$659	﹤0.01%	9485
2023 Q2	–	Sell	-16	Closed	-$405	–	9798
2023 Q1	$0	Sell	16 -3	-16%	-$77	﹤0.01%	9981
2022 Q4	$0	Buy	+19	New	+$483	﹤0.01%	10245

Other funds holding RXD

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's RXD Position: Q2 2025 in Review

Simplex Trading sold out of ProShares UltraShort Health Care (RXD) in Q2 2025, closing a stake of 81 shares — an estimated $1.98K sold.

Simplex Trading first reported a position in RXD in Q4 2022 and held it in 4 quarters. The position peaked at $1K in Q1 2025. 4 funds tracked by Wall St. Rank hold RXD as of Q2 2025.

Simplex Trading reported no remaining ProShares UltraShort Health Care position as of Q2 2025 after selling out during the quarter.
Simplex Trading sold 81 ProShares UltraShort Health Care shares in Q2 2025, an estimated $1.98K.
Simplex Trading first reported a position in ProShares UltraShort Health Care in Q4 2022 and held it in 4 quarters.
Simplex Trading's ProShares UltraShort Health Care position peaked at $1K in Q1 2025.
4 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.